Patients with untreated advanced melanoma do not appear to gain a survival advantage from the addition of a cancer vaccine to pembrolizumab, suggests a trial.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/adding-vaccine-pembro-did-not-improve-pfs-melanoma-2025a1000t1q?src=rss
Author :
Publish date : 2025-10-24 14:25:00
Copyright for syndicated content belongs to the linked Source.
